DMIIR NASDAQ
Drugs Made In America Acquisition II Corp. Right
1W: -7.0%
1M: +21.0%
3M: -31.3%
YTD: -42.9%
$0.09
+0.01 (+12.50%)
Weekly Expected Move ±33.9%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.7M
52W Range0.09-0.09
Volume10,275
Avg Volume110,896
Beta2.69
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORoger Bendelac
SectorFinancial Services
IndustryAsset Management
IPO Date2025-12-04
Websitedmaacorp.com/
1 East Broward Boulevard
Fort Lauderdale, FL 33301
US
Fort Lauderdale, FL 33301
US
954 870 3099
About Drugs Made In America Acquisition II Corp. Right
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Latest News
No recent news
Recent Insider Trades
No insider trades found